Phage therapy combats antibiotic resistance

The Israeli Phage Therapy Center (IPTC), led by two Hebrew University of Jerusalem professors, has used a bacteriophage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections in 16 patients. It has shown promising results with an 86.6% success rate.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *